Accelerating evidence generation to implementation: Establishment of the Leading Awareness to Action through...

Area of Science:

• Cardiology
• Metabolic Disorders
• Implementation Science

Background:

• Cardiovascular disease and metabolic disorders are leading causes of mortality globally.
• Translating scientific advancements into clinical practice is often slow, limiting patient benefit.
• The gap between evidence generation and healthcare implementation necessitates scalable solutions.

Purpose of the Study:

• To establish the Leading Awareness to Action through Implementation of Cardiometabolic Efforts (LATTICE™) consortium.
• To create a collaborative platform for sharing evidence-based tools and strategies for cardiometabolic health.
• To accelerate the implementation of innovative therapies to reduce cardiometabolic events.

Main Methods:

• Exploring novel strategies for translating evidence-based advancements into diverse clinical settings.
• Disseminating successful strategies through collaboration among stakeholders (clinicians, payors, patients, industry).
• Prioritizing projects that rigorously test implementation science strategies for scalability.

Main Results:

• The LATTICE consortium was established in 2023 to unite partners focused on improving cardiometabolic health.
• The consortium facilitates the sharing of tools, methodologies, and strategies to address care gaps.
• Focus on scalable and sustainable healthcare strategies for widespread adoption.

Conclusions:

• The LATTICE consortium aims to improve awareness, access, and implementation of effective cardiometabolic care strategies.
• Successful implementation will lead to reduced morbidity and mortality from cardiometabolic events.
• Collaboration and implementation science are key to achieving population-level benefit in cardiometabolic health.